SD Biotechnologies Co., Ltd. (KOSDAQ:A217480) agreed to acquire a 38.636208% stake in IMMUNOBIOTECH Corp. from KOSSEN Co., Ltd. (KOSDAQ:A009730) for KRW 5.3 billion on July 25, 2022. As of November 30, 2022, the board of directors of SD Biotechnologies Co., Ltd approved the transaction.

The transaction is expected to close on November 30, 2022. The transaction is now expected to complete on December 30, 2022. As of December 30, 2022, The board resolution date is December 30, 2022.

SD Biotechnologies will acquire 1.29957 million shares. The acquisition price has changed to KRW 4.13 billion.